Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis IBT-B

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History IBT-B

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – SEK
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth IBT-B

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin IBT-B

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income IBT-B

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM IBT-B

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio IBT-B

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Infant Bacterial Therapeutics AB (publ) IBT-B

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself IBT-B

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 190 957.28
Enterprise Value EBITDA -3.91
Price Book MRQ 5.25

Infant Bacterial Therapeutics AB (publ) Dividends: – Yield, History, Payment Schedule

IBT-B
Current price
45.05 SEK -0.25 SEK (-0.55%)
Last closed 45.00 SEK
ISIN SE0008015259
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 707 206 687 SEK
Yield for 12 month -4.96 %
1Y
3Y
5Y
10Y
15Y
IBT-B
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+4 015 SEK

Last Year

+77 210 SEK

Current Quarter

Last Quarter

Current Year

+4 015 SEK

Last Year

+77 210 SEK

Current Quarter

Last Quarter

EBITDA -134 163 568 SEK
Operating Margin TTM 10 888 700.00 %
Price to Earnings
Return On Assets TTM -27.80 %
PEG Ratio
Return On Equity TTM -55.16 %
Wall Street Target Price 2 820.98 SEK
Revenue TTM -1 003 SEK
Book Value 12.67 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -61.50 %
Dividend Yield
Gross Profit TTM -1 003 SEK
Earnings per share -7.62 SEK
Diluted Eps TTM -7.62 SEK
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY -61.70 %
Profit Margin

Technical Indicators IBT-B

For 52 Weeks

31.28 SEK 84.53 SEK
50 Day MA 66.09 SEK
Shares Short Prior Month
200 Day MA 53.95 SEK
Short Ratio
Shares Short
Short Percent